One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Development of Transcriptome Sequencing TechnologyApril 4, 2023Transcriptome refers to the total sum of all expressed genes in a specific cell under specific functional conditions, which includes all transcript information of a cell. Typically, transcriptome anal...view
Concept and Application of Microarray PlatformsApril 16, 2025Concept of Microarray PlatformsA microarray platform is a high-throughput experimental platform based on miniaturization technology. It can simultaneously detect and analyze multiple biomolecules (suc...view
Advantages of NGS Genetic TestingApril 16, 2025What is NGS Genetic Testing?Genes are sequences that store all the genetic information of life. Gene sequences are primarily inherited from parents, but genes in different cells can also mutate. Nobel...view
Struggling to Lose Weight? Obesity Genetic Test May Reveal WhyNovember 13, 2024Obesity Genetic Test: Making Your Weight Loss Efforts More EffectiveWhy do some people find it very difficult to lose weight? And why do some people rarely gain weight regardless of how much they eat?...view